Provided by Tiger Trade Technology Pte. Ltd.

Shattuck Labs, Inc.

8.02
+0.12001.52%
Volume:258.52K
Turnover:2.08M
Market Cap:804.91M
PE:-16.01
High:8.15
Open:8.01
Low:7.93
Close:7.90
52wk High:8.33
52wk Low:0.9200
Shares:100.36M
Float Shares:67.76M
Volume Ratio:0.84
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5010
EPS(LYR):-0.7014
ROE:-39.21%
ROA:-24.43%
PB:3.81
PE(LYR):-11.43

Loading ...

Shattuck Labs Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Shattuck Labs Q1 EPS $(0.13), Inline

Benzinga Earnings
·
May 07

BRIEF-Shattuck Labs Q1 Net Income USD -14.767 Million

Reuters
·
May 07

Shattuck Labs Q1 FY26 net loss widens to $14.8 million; R&D expenses rise to $10.9 million

Reuters
·
May 07

Shattuck Labs Q1 Income From Operations USD -15.545 Million

THOMSON REUTERS
·
May 07

Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights

GlobeNewswire
·
May 07

Shattuck Labs Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Apr 27

Cantor Fitzgerald Initiates Coverage on Shattuck Labs With Overweight Rating

MT Newswires Live
·
Apr 27

Shattuck Labs initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
Apr 27

Shattuck Labs Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
Apr 27

Shattuck Labs Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 20

Shattuck Labs price target raised to $18 from $6 at H.C. Wainwright

TIPRANKS
·
Apr 20

Shattuck Labs announces annual shareholder meeting notice

Reuters
·
Apr 08

Shattuck Labs management to meet with Piper Sandler

TIPRANKS
·
Apr 02

Shattuck Labs Is Maintained at Neutral by Citigroup

Dow Jones
·
Mar 14

Citi ups Shattuck Labs target, opens ‘upside 90-day catalyst watch’

TIPRANKS
·
Mar 13

Shattuck Labs Is Maintained at Outperform by Wedbush

Dow Jones
·
Mar 06

Wedbush Raises Price Target on Shattuck Labs to $8 From $4, Keeps Outperform Rating

MT Newswires Live
·
Mar 06

Shattuck Labs Publishes Corporate Presentation on DR3-Blocking Antibodies for Inflammatory and Immune-Mediated Diseases

Reuters
·
Mar 05

Shattuck Labs expects available cash to fund operations into 2029

TIPRANKS
·
Mar 05